DOI: 10.2337/diaclin.26.1.17 © 2008 by the American Diabetes Association
Working With Patients to Enhance Medication Adherence
Helping patients take medications effectively is a key clinical undertaking. Optimal medication adherence improves clinical outcomes and can even lower health care costs by reducing morbidity and decreasing health care use.1 Benefits are especially striking in patients with diabetes.2,3 Across chronic illnesses, patients take only 50% of medications
prescribed for those
conditions.4,5
Similar patterns are seen in patients with
diabetes,6
particularly in those who also have depressive symptoms. Among depressed
patients with diabetes, for example, nonadherence to hypoglycemic and
antihypertensive agents is even lower than among nondepressed patients with
diabetes.7,8
Even among nondepressed patients, levels of medication adherence may be
significantly lower than desired because of side effects and lack of
motivation to take the medications as prescribed.
Patients, health care providers, and health care systems all play a role in creating this quality and outcome gap between current reality and optimal diabetes management.9,10 Barriers to effective use of medicines for diabetes care include: 1) poor provider-patient communication; 2) inadequate knowledge about a drug and its use (in both patients and clinicians); 3) psychological insulin resistance;11 4) complex regimens that require numerous medications with varying dosing schedules; 5) lack of follow-up to monitor treatment response; 6) lack of treatment titration to achieve optimal outcomes; and 7) cost and access barriers.9,12,13 The current lack of provider time and shortage of clinic resources to support good chronic illness care for diabetes further widens the quality gap. Additional health care system supports are necessary to reduce cost and access barriers and to enhance appropriate intensification of treatment and follow-up (barriers 5-7). Nevertheless, primary care physicians and teams can use evidence-based approaches for increasing collaboration with their patients as a way for improving adherence and clinical outcomes. The following clinical actions summarize systematic reviews of the literature and combine patient-centered approaches aimed at achieving better medication adherence and diabetes outcomes.9,12,14-16
Diabetes-related choices that patients make each day may have more impact than physicians' recommendations alone on how well diabetes is managed. Nevertheless, at the time of health care visits, offering information, education, and steps to motivate patients about their diabetes self-care behaviors—glucose monitoring, healthy nutrition, physical activity, and medication taking—is key for optimal management. In other words, patients are in charge of managing their diabetes, but clinicians are important advisors and can provide assistance and support. Thus, providers have an important role that is best accomplished in a patient-provider or patient-health team partnership.
If possible, include family members and audiovisual aids at the time of initial prescribing of a medication. Address the key information (what, why, when, how, and how long) as follows:
Simple written information and instructions, in addition to verbal instructions, are necessary. Large preprinted labels can be affixed to the medication container for easy reference (Figure 1).
Keep in mind that reducing the frequency of dosing is more important than the number of pills in a dose.
Optimal diabetes care is achievable if clinicians collaborate with patients in managing diabetes and if health care systems support systematic patient response monitoring and enhance treatment titration to achieve favorable diabetes outcomes with minimal complications. A first step in working with patients is recognizing that not "taking medications as directed" is common. Useful clinical encounters and approaches include a nonjudgmental assessment of medication-taking, clear explanations about how to use medications, simplified regimens, and scheduled follow-up visits or telephone calls to monitor progress and adjust treatment. Such practical approaches are ones that health care providers and patients can use in a busy primary care setting.
Elizabeth H.B. Lin, MD, MPH, is a family medicine physician and affiliate scientific investigator at the Center for Health Studies, Group Health Cooperative in Seattle, Wash. She is also a clinical professor. Paul Ciechanowski, MD, MPH, is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine in Seattle.
1 Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS: Impact of medication adherence on hospitalization risk and healthcare cost. Med Care43 : 521-530,2005[Medline] 2 Ho PM, Rumsfeld
JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ: Effect of
medication nonadherence on hospitalization and mortality among patients with
diabetes mellitus. Arch Intern Med166
: 1836-1841,2006 3 Rhee MK, Slocum W,
Ziemer DC, Culler SD, Cook CB, El-Kebbi IM, Gallina DL, Barnes C, Phillips LS:
Patient adherence improves glycemic control. Diabetes
Educ 31: 240-250,2005 4 Haynes RB,
McDonald HP, Garg AX: Helping patients follow prescribed treatment: clinical
applications. JAMA 288:2880
-2883, 2002 5 DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW: Patient adherence and medical treatment outcomes: a meta-analysis. Med Care40 : 794-811,2002[Medline] 6 Rubin RR: Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 118 (Suppl. 5A): 27S-34S, 2005[Medline] 7 Lin EHB, Katon
WVKM, Rutter C, Simon GE, Oliver M, Ciechanowski P, Ludman E, Bush T, Young B:
Relationship of depression and diabetes self-care, medication adherence and
preventive care. Diabetes Care27
: 2154-2160,2004 8 Ciechanowski PS,
Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on
adherence, function, and costs. Arch Intern Med160
: 3278-3285,2000 9 Osterberg L,
Blaschke T: Adherence to medication. N Engl J Med353
: 487-497,2005 10 Wagner EH, Glasgow RE, Davis C, Bonomi AE, Provost L, McCulloch D, Carver P, Sixta C: Quality improvement in chronic illness care: a collaborative approach. Jt Comm J Qual Improv 27:63 -80, 2001[Medline] 11 Polonsky WH,
Fisher L, Guzman S, Villa-Caballero L, Edelman SV: Psychological insulin
resistance in patients with type 2 diabetes: the scope of the problem.
Diabetes Care 28:2543
-2545, 2005 12 Tarn DM, Heritage
J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS: Physician communication when
prescribing new medications. Arch Intern Med166
: 1855-1862,2006 13 Rodondi N, Peng T,
Karter AJ, Bauer DC, Vittinghoff E, Tang S, Pettitt D, Kerr EA, Selby JV:
Therapy modifications in response to poorly controlled hypertension,
dyslipidemia, and diabetes mellitus. Ann Intern Med144
: 475-484,2006 14 Glasgow RE, Davis CL, Funnell MM, Beck A: Implementing practical interventions to support chronic illness self-management. Jt Comm J Qual Saf29 : 563-574,2003[Medline] 15 Funnell MM, Kruger
DF, Spencer M: Self-management support for insulin therapy in type 2 diabetes.
Diabetes Educ 30:274
-280, 2004 16 Kripalani S, Yao
X, Haynes RB: Interventions to enhance medication adherence in chronic medical
conditions: a systematic review. Arch Intern Med167
: 540-549,2007 17 Polonsky WH,
Earles J, Smith S, Pease DJ, Macmillan M, Christensen R, Taylor T, Dickert J,
Jackson RA: Integrating medical management with diabetes self-management
training: a randomized control trial of the Diabetes Outpatient Intensive
Treatment program. Diabetes Care26
: 3048-3053,2003
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||